Under terms of the agreement, GenomOncology’s GO Clinical Workbench™ will now support interpretation of multiple ArcherDX assays, including ALK, RET, ROS1, Solid Tumor, and Comprehensive Thyroid and Lung (CTL) panels.
ArcherDX CEO Jason Myers said: "Using Archer’s assays with GenomOncology’s reporting software will be of great benefit to molecular laboratories.
"Archer’s assays are comprehensive by design, and our workflow makes it easy to generate a list of variants from low-input FFPE samples."
ArcherDX director of pharma business development Jill Stefanelli said: "GenomOncology’s GO Clinical Workbench will empower labs of all sizes to run and annotate ArcherDX NGS assays, from both RNA and DNA aberrations. Furthermore, inclusion of a rules-based reporting pipeline provides a much-needed step towards standardization of NGS methodologies."
GenomOncology CEO Manuel Glynias said: "Archer’s assays are highly regarded by molecular pathologists and researchers alike.
"Through this partnership, the companies will together facilitate the most streamlined and complete testing and decision support solutions for our clients."
The incorporation of GenomOncology’s GO Clinical Workbench into the workflow will allow customers to move directly from a list of variants to a knowledge-driven interpretive report, enabling laboratories of all sizes to get meaningful results from targeted NGS assays.
Archer VariantPlex and FusionPlex assays are purpose-built to detect oncogenic fusions, RNA abundance, copy number variations (CNVs), single nucleotide variants (SNVs) and insertions/deletions (indels) from FFPE samples.
Archer’s Solid Tumor and Comprehensive Thyroid and Lung (CTL) assays combine both RNA- and DNA-based sequencing assays into a single workflow, allowing comprehensive profiling of multiple tumor types in a rapid, economical manner.
The GO Clinical Workbench is part of the The GO Precision Medicine Portfolio, a full suite of tools designed to help healthcare institutions implement, perform, and maximize the benefits of precision medicine. The tools are installed behind the institution’s firewall and are configured to each laboratory’s specific needs.